News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Marshall Keith W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 87,973 shares
@ $0
Disposed/sold 52,838 options to buy
@ $3.1, valued at
$163.8k
Disposed/sold 93,040 options to buy
@ $3.7, valued at
$344.2k
Disposed/sold 135,913 options to buy
@ $6.7, valued at
$910.6k
Disposed/sold 102,155 options to buy
@ $36.32, valued at
$3.7M
Disposed/sold 86,582 options to buy
@ $29.56, valued at
$2.6M
Disposed/sold 34,085 options to buy
@ $110.2, valued at
$3.8M
Disposed/sold 12,920 options to buy
@ $108.76, valued at
$1.4M
|
|
| 06/02/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Exercised 78,162 options to buy
@ $3.1, valued at
$242.3k
|
|
| 03/08/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 10,000 shares
@ $122.13, valued at
$1.2M
Exercised 10,000 options to buy
@ $3.7, valued at
$37k
|
|
| 01/19/2023 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $119, valued at
$595k
Exercised 5,000 options to buy
@ $3.7, valued at
$18.5k
|
|
| 12/20/2022 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 12,920 options to buy
@ $108.76, valued at
$1.4M
|
|
| 12/13/2022 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 9,811 shares
@ $0
Granted 34,085 options to buy
@ $110.2, valued at
$3.8M
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 102,155 options to buy
@ $36.32, valued at
$3.7M
|
|
| 05/27/2020 |
4
| Marshall Keith W (EVP, COO & CFO) has filed a Form 4 on Histogen Inc.|
Txns:
| Paid exercise price by delivering 18,615 shares
@ $0.56, valued at
$10.4k
Exercised 38,500 restricted stock units
@ $0 |
|
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2018 |
4
| Marshall Keith W (EVP, COO & CFO) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 70,000 options to buy
@ $5.17, valued at
$361.9k
|
|
| 09/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|